Abstract
Atherosclerosis, a lipid-driven inflammatory disease of large arteries, is a leading cause of cardiovascular disease. While lipid-lowering therapies are effective, some patients retain a residual inflammatory risk, highlighting the need for alternative anti-inflammatory treatments. This thesis investigates the therapeutic potential of immune checkpoint modulation in preclinical models of
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 20 Mar 2025 |
| Print ISBNs | 9789465104416 |
| Publication status | Published - 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Exploring the therapeutic potential of immune checkpoint modulation in preclinical models of inflammatory diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver